CATHERINE PINCKLEY: Open Payments
NPI 1669553913 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 76 payments from 18 companies in 2025. Trend: 2023 $477 · 2024 $726 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $216 |
| PFIZER INC. | 17 | $173 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $152 |
| Novartis Pharmaceuticals Corporation | 8 | $126 |
| AstraZeneca Pharmaceuticals LP | 6 | $93 |
| E.R. Squibb & Sons, L.L.C. | 5 | $79 |
| Baxter Healthcare | 2 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: ELIQUIS, VERQUVO, LifeVest, LEQVIO, FARXIGA, Hillrom - Carnation Ambulatory Monitor, VYNDAQEL, EVKEEZA.
Industry payments across LA — which companies pay providers there.
